CGCN GROUP, LLC lobbying for ERADIVIR

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 10545
American Relief Act, 2025

Lobbying activity 3

Budget/Appropriations

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.

Disaster Planning/Emergencies

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.

Health Issues

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.